Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia

Laurence Neff1, Sawsan Daher, Patrick Muzzin

  • 1Division of Rheumatology, Department of Internal Medicine, University Hospital, 1211 Geneva 14, Switzerland.

Insights

Macrophage infectivity potentiator (MIP) is a chlamydial lipoprotein with a confirmed lipid modification. This study characterized MIP

Area of Science:

  • Microbiology
  • Biochemistry
  • Structural Biology

Background:

  • Macrophage infectivity potentiator (MIP) is a chlamydial lipoprotein.
  • Previous studies suggested MIP is a lipoprotein, but its lipid structure was not fully characterized.
  • Chlamydial lipoproteins are crucial for bacterial survival and pathogenesis.

Purpose of the Study:

  • To elucidate the detailed structure of the lipid moiety on MIP.
  • To determine the subcellular localization of MIP in Chlamydia trachomatis.
  • To confirm the lipoprotein nature of MIP and its processing.

Main Methods:

  • Bioinformatics and in silico analysis of MIP sequence.
  • Radiolabeling experiments with [U-(14)C]palmitic acid and U-(14)C-esterified glycerol.
  • Globomycin inhibition assays to assess posttranslational processing.
  • Gas chromatography-mass spectrometry (GC-MS) for fatty acid analysis.
  • Alkaline methanolysis to investigate amide-linked fatty acids.
  • Surface biotinylation and immunoprecipitation for subcellular localization.

Main Results:

  • MIP sequence is conserved across chlamydial species with a conserved lipobox.
  • Lipid modification of MIP was confirmed, involving incorporation of fatty acids and glycerol.
  • Globomycin inhibited MIP processing, indicating signal peptidase II involvement.
  • GC-MS and alkaline methanolysis confirmed amide-linked fatty acids, typical of prokaryotic lipoproteins.
  • MIP was localized to the outer membrane of Chlamydia trachomatis elementary bodies and present on their surface.

Conclusions:

  • MIP is a prokaryotic lipoprotein with a conserved structure and lipid modification.
  • MIP is processed similarly to other bacterial lipoproteins.
  • MIP is localized to the outer membrane and surface of Chlamydia trachomatis elementary bodies.
  • These findings enhance understanding of chlamydial outer membrane protein structure and function.